---
document_datetime: 2023-09-21 19:06:54
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/amyvid-epar-all-authorised-presentations_en.pdf
document_name: amyvid-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.9248505
conversion_datetime: 2025-12-18 23:59:21.820711
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength    | Pharmaceutical Form    | Route of Administration   | Immediate Packaging   | Content (concentration)   | Pack size   |
|------------------|-------------------|-------------|------------------------|---------------------------|-----------------------|---------------------------|-------------|
| EU/1/12/805/001  | Amyvid            | 800 MBq/ml  | Solution for injection | Intravenous use           | vial (glass)          | 1-10 ml                   | 1 vial      |
| EU/1/12/805/002  | Amyvid            | 800 MBq/ml  | Solution for injection | Intravenous use           | vial (glass)          | 1-15 ml                   | 1 vial      |
| EU/1/12/805/003  | Amyvid            | 1900 MBq/ml | Solution for injection | Intravenous use           | vial (glass)          | 1-10 ml                   | 1 vial      |
| EU/1/12/805/004  | Amyvid            | 1900 MBq/ml | Solution for injection | Intravenous use           | vial (glass)          | 1-15 ml                   | 1 vial      |